Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. CbdMD, Inc.
  6. News
  7. Summary
    YCBD   US12482W1018

CBDMD, INC.

(YCBD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

cbdMD : Receives Prestigious U.S. Hemp Authority™ Certification

05/10/2021 | 10:01am EDT

cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the nation’s leading and most highly trusted and recognized cannabidiol (CBD) brands, announced today that it has received the prestigious U.S. Hemp Authority™ Certification (USHA).

The certification signifies the Company's efforts to provide a high-quality, trustworthy product and grants the right to use the Certified Seal of the U.S. Hemp Authority on all hemp product packaging and marketing materials. In addition to the Company’s NSF GMP registration, the USHA Certification further validates that cbdMD adheres to the highest standards and provides consumers with the highest quality hemp extracted cannabinoid products.

Issued by leading food standards auditing company Food Chain ID, the USHA Certification includes a third party audit which covers topics such as maintaining a quality management system, meeting applicable ISO and cGMP standards, implementing standard operating procedures, and ensures compliance with relevant Federal regulations.

“We know that consumers choose cbdMD because of the commitment we make to the quality and safety of our products. As a market leader and leading recognized consumer CBD brand, it is critical that our consumers know that when they use a cbdMD product it is double-tested by third-party laboratories for purity and potency and that our manufacturing has been audited and validated to meet GMP by NSF, and now we have added the highly coveted U.S. Hemp Authority Certification,” said Martin Sumichrast, Chairman & Co-CEO of cbdMD, Inc.

About cbdMD, Inc.

cbdMD, Inc. is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products. Our cbdMD brand currently includes over 130 SKUs of high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD bath bombs, CBD bath salts, CBD sleep aids and CBD drink mixes. Our Paw CBD brand of pet products includes over 45 SKUs of veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and our CBD Botanicals brand of beauty and skincare products features 15 SKUs, including facial oil and serum, toners, moisturizers, clear skin, facial masks, exfoliants and body care. To learn more about cbdMD and their comprehensive line of U.S. grown, THC-free1 CBD oil products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook, or visit one of the 6,000 retail outlets that carry cbdMD products.

1 THC-free is defined as below the level of detection using validated scientific analytical methods.

Forward-Looking Statements

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ''should,'' ''may,'' ''intends,'' ''anticipates,'' ''believes,'' ''estimates,'' ''projects,'' ''forecasts,'' ''expects,'' ''plans,'' and ''proposes.'' These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" in cbdMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended September 30, 2020 as filed with the Securities and Exchange Commission (the "SEC") on December 22, 2020, Item 1A. Risk Factors, contained in our Quarterly Report on Form 10-Q for the period December 31, 2020 as filed with the SEC on February 9, 2021 and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.


© Business Wire 2021
All news about CBDMD, INC.
07/30CBDMD : What Is Muscular Endurance?...
PU
07/30CBDMD : What Is Melatonin? What it's Used for & Why We Love it...
PU
07/28SKIN CARE ROUTINE : How to Take Care of All Skin Types...
PU
07/28CBDMD : How To Rebuild A Social Connection...
PU
07/27CBDMD : Announces the Closed Purchase of DirectCBDOnline.com (Form 8-K)
PU
07/27CBDMD, INC. : Entry into a Material Definitive Agreement, Change in Directors or..
AQ
07/27CbdMD, Inc. Appoints John J. Wiesehan III as Chief Revenue Officer
CI
07/27CBDMD : How Does CBD Oil Make You Feel?...
PU
07/25CBDMD : 4 Ideas for Experiencing New Things This Summer...
PU
07/24CBDMD : What Is CBD Oil? Here's What You Need To Know...
PU
More news
Financials (USD)
Sales 2021 50,2 M - -
Net income 2021 -26,0 M - -
Net cash 2021 19,6 M - -
P/E ratio 2021 -5,73x
Yield 2021 -
Capitalization 152 M 152 M -
EV / Sales 2021 2,64x
EV / Sales 2022 2,29x
Nbr of Employees 165
Free-Float 63,7%
Chart CBDMD, INC.
Duration : Period :
cbdMD, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CBDMD, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 2,58 $
Average target price 5,42 $
Spread / Average Target 110%
EPS Revisions
Managers and Directors
Martin A. Sumichrast Chairman & Co-Chief Executive Officer
Raymond Scott Coffman President, Co-Chief Executive Officer & Director
T. Ronan Kennedy Chief Operating & Financial Officer
Sibyl Swift Vice President-Scientific & Regulatory Affairs
Bakari Sellers Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CBDMD, INC.-12.54%152
JOHNSON & JOHNSON9.42%453 313
ROCHE HOLDING AG13.38%337 105
PFIZER, INC.16.30%239 637
NOVARTIS AG0.28%225 343
ELI LILLY AND COMPANY44.22%221 348